Skip to content

Medical-device intelligence

JBQ: Antithrombin Iii Quantitation

FDA product code JBQ: Antithrombin Iii Quantitation. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
JBQ
FDA device name
Antithrombin Iii Quantitation
Device class
2
Regulation number
864.7060
Medical specialty
Hematology
Review panel
HE

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore hematology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

56 clearance records and 0 recall records in the covered releases, across 40 source company names and 1 product codes. Dated history runs from Mar 30, 1977 to Mar 28, 2025.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
JBQ · Antithrombin Iii Quantitation560

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

56 matching records
Device / recordCompany in FDA recordSourceSource date
INNOVANCE AntithrombinK242952 · JBQSiemens Healthcare Diagnostic Products GmbH510(k)Mar 28, 2025FDA decision date
INNOVANCE ANTITHROMBIN WITH MODELS OPFH03, OPFHO5K081769 · JBQSiemens Healthcare Diagnostics510(k)May 28, 2009FDA decision date
HEMOSIL ANTITHROMBINK070301 · JBQInstrumentation Laboratory CO510(k)Feb 23, 2007FDA decision date
HEMOSIL LIQUID ANTITHROMBINK062431 · JBQInstrumentation Laboratory CO510(k)Sep 1, 2006FDA decision date
BIOPHEN ANTITHROMBIN 2.5, REFERENCE # 221102; BIOPHEN ANTITHROMBIN 5, REFERENCE # 221105K043007 · JBQHyphen Biomed510(k)Nov 7, 2005FDA decision date
HEMOSIL LIQUID ANTITHROMBIN XLK033775 · JBQInstrumentation Laboratory CO510(k)Jan 2, 2004FDA decision date
CHROMOCHECK ANTITHROMBIN 25; CHROMOCHECK ANTITHROMBIN 50K023991 · JBQPrecision Biologic510(k)Apr 28, 2003FDA decision date
COAMATIC LR ANTITHROMBIN, NOTE: LR=LIQUID REAGENTSK022550 · JBQInstrumentation Laboratory CO510(k)Aug 27, 2002FDA decision date
COAMATIC AT-400K022195 · JBQInstrumentation Laboratory CO510(k)Aug 7, 2002FDA decision date
IL TEST LIQUID ANTITHROMBINK994238 · JBQInstrumentation Laboratory CO510(k)Jun 23, 2000FDA decision date
K-ASSAY AT-IIIK000361 · JBQKamiya Biomedical Co.510(k)Apr 26, 2000FDA decision date
IL TEST ANTITHROMBINK980499 · JBQInstrumentation Laboratory CO510(k)Apr 2, 1998FDA decision date
IMMAGE IMMUNOCHEMISTRY SYSTEM ANTITHROMBIN III (AT3) REAGENTK974110 · JBQBeckman Instruments, Inc.510(k)Dec 24, 1997FDA decision date
SIGMA DIAGNOSTICS ACCUCOLOR ANTITHROMBIN IIIK972144 · JBQSigma Diagnostics, Inc.510(k)Jul 25, 1997FDA decision date
SPECTROLYSE ANTITHROMBIN III (ANTI-XA)K960871 · JBQMedical Diagnostic Technologies, Inc.510(k)Aug 14, 1996FDA decision date
COACUTE ANTITHROMBIN R CHROMOGENIC ASSAYK952515 · JBQChromogenix AB510(k)Jan 23, 1996FDA decision date
CHROM Z CHROMOGENIC ASSAYSK951943 · JBQHelena Laboratories510(k)Nov 13, 1995FDA decision date
AT-III CALIBRATORK944279 · JBQAmerican Bioproducts Co.510(k)Apr 7, 1995FDA decision date
BIOMERIEUX HEMOLAB AT IIIK934156 · JBQBiomerieux Vitek, Inc.510(k)Dec 22, 1994FDA decision date
ACCUCOLOR(TM) ANTITHROMBIN III CHROMOGENIC ASSAYK935308 · JBQSigma Diagnostics, Inc.510(k)May 17, 1994FDA decision date
ANTITHROMBIN III CHROMOGENIC ASSAYK936196 · JBQBaxter Diagnostics, Inc.510(k)May 4, 1994FDA decision date
COATEST(R) ANTITHROMBIN III, MODIFICATIONK931420 · JBQKabi Pharmacia Hepar, Inc.510(k)May 2, 1994FDA decision date
ANTITHROMBIN III IMMUNOLOGICAL NL TEST KITK913667 · JBQThe Binding Site, Ltd.510(k)Jan 3, 1992FDA decision date
COAMATE(R) ANTITHROMBIN CHROMOGENIC ASSAYK915083 · JBQKabi Pharmacia, Inc.510(k)Jan 3, 1992FDA decision date
LIATEST(R) AT III TEST KITK905110 · JBQAmerican Bioproducts Co.510(k)Jan 24, 1991FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗